The latter effect has also been proposed to be moderated by a genetic polymorphism in the IL6 gene promoter, which regulates the beta-adrenergic activation of IL6 transcription, in individuals with impaired glucose tolerance [55,56]. Here, IL6 is linked to Impaired glucose tolerance.